Winston AI writes a plain-English brief of every opportunity — what the buyer wants, and what affects whether to bid. It's free in every Scout workspace. Sign in to see it.
The People's Dispensary for Sick Animals (PDSA) intends to procure a new contractual arrangements for the supply and support of veterinary pharmaceutical products to its network of Pet Hospitals and operational sites across the United Kingdom.
This Expression of Interest (EOI) relates to a forthcoming procurement for veterinary pharmaceutical products, consumables, pet foods and associated support products. The procurement is intended to establish contractual arrangements with suitably qualified suppliers capable of supporting PDSA's national clinical operations.
This EOI is intended only for organisations with demonstrable capability and experience in the manufacture, supply, distribution, or authorised marketing of veterinary pharmaceuticals within regulated UK supply environments. PDSA is seeking suppliers capable of supporting one or more categories of veterinary pharmaceutical products. Suppliers may express interest in individual product groups, therapeutic categories, or broader portfolio arrangements.
PDSA is seeking interest from suppliers who can evidence:
This EOI is not intended for organisations without relevant regulatory standing, sector experience, or operational capability to deliver the products and services described.
A full Invitation to Tender, including detailed requirements, product specifications, evaluation criteria, and procurement timescales, will be issued in due course to organisations that register their interest and are considered capable of meeting PDSA's requirements.
Register interest by contacting tenders@pdsa.org.uk, quoting "Veterinary Pharmaceutical Supply - EOI" in the subject line.
Sign in to tag this notice and share notes on it with your team.
Registration of interest does not constitute a commitment by PDSA to invite any organisation to tender, nor does it form part of any pre-qualification or guarantee progression to the ITT stage.